News
Asthma
Scope 66 - Allergic disease research pays tribute to 30-year...
The Malaghan Institute’s allergic disease programme recently published a paper that h...
Health Research Council backs Malaghan Institute to continue...
The Malaghan Institute of Medical Research’s outstanding programmes of scientific dis...
Malaghan researchers identify new role for key molecule in e...
Researchers at the Malaghan Institute of Medical Research have identified the role a ...
Scope 63 - Out of the box approaches to treating Asthma
Asthma is caused by an overreaction of the immune system to harmless environmental tr...
Professor Graham Ogg visiting the Malaghan Institute
Earlier this week we welcomed Professor Graham Ogg, Professor of Dermatology, MRC Hum...
Research Report 2016 - Asthma, Allergy and Parasitic Disease...
The Asthma, Allergy and Parasitic Diseases group uses studies of allergens and parasi...
Promising results for combination therapy for acute leukaemi...
Acute leukaemias are among the most aggressive cancers the number of leukaemia cell...
The Allergy Epidemic: TV One Sunday 1 February
Our Director of Research Graham Le Gros will share his insights into New Zealands...
What's an adjuvant?
An adjuvant is a substance that is administered with a vaccine to enhance its effect ...
Breathing easier creating a vaccine for asthma
We were delighted to announce the patenting and publication of our novel vaccine ther...